1. Home
  2. GOSS vs HFWA Comparison

GOSS vs HFWA Comparison

Compare GOSS & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.57

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$24.90

Market Cap

748.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
HFWA
Founded
2015
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
726.8M
748.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
GOSS
HFWA
Price
$3.57
$24.90
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$8.60
$29.33
AVG Volume (30 Days)
3.3M
200.6K
Earning Date
11-05-2025
01-22-2026
Dividend Yield
N/A
3.71%
EPS Growth
N/A
53.03
EPS
N/A
1.65
Revenue
$44,051,000.00
$232,877,000.00
Revenue This Year
N/A
$21.61
Revenue Next Year
$6.41
$29.10
P/E Ratio
N/A
$15.66
Revenue Growth
N/A
14.16
52 Week Low
$0.76
$19.84
52 Week High
$3.87
$26.09

Technical Indicators

Market Signals
Indicator
GOSS
HFWA
Relative Strength Index (RSI) 56.81 60.33
Support Level $3.53 $25.19
Resistance Level $3.87 $26.09
Average True Range (ATR) 0.24 0.52
MACD -0.02 0.07
Stochastic Oscillator 51.96 56.11

Price Performance

Historical Comparison
GOSS
HFWA

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: